🇺🇸 FDA
Pipeline program

Atomoxetin STADA 40 mg Hartkapseln, GELATIN

D24-P017

Phase 2 small_molecule active

Quick answer

Atomoxetin STADA 40 mg Hartkapseln, GELATIN for Healthy subjects with no neurological or psychiatric disorders is a Phase 2 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Healthy subjects with no neurological or psychiatric disorders
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials